GlassScriptPhysician profile
Nasir Rahmatullah
NPI 1679503684
$1,634.08
in general payments reported to CMS, 2019-2025
19 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $296 · 2021: $442 · 2022: $129 · 2023: $165 · 2024: $319 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $607.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $607.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $416.19 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $392.51 | 2019-2025 | Jardiance |
| Kestra Medical Technology Services, INC. | $152.53 | 2024-2025 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $140.79 | 2019-2024 | Airsupra, Breztri |
| Amgen INC. | $114.74 | 2019-2023 | Repatha |
| Lilly USA, LLC | $55.72 | 2023-2024 | Jardiance |
| Exact Sciences Corporation | $51.70 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Medtronic, INC. | $50.60 | 2023-2025 | Resolute Onyx, Symplicity G3 |
| Novo Nordisk INC | $45.45 | 2020-2025 | Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $33.84 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $33.83 | 2024 | Xifaxan |
| Abbott Laboratories | $27.30 | 2024 | Freestyle Libre 3 |
| Cvrx, INC. | $24.85 | 2024 | Barostim Neo System |
| Genentech USA, INC. | $22.48 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $17.12 | 2024 | Camzyos |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $16.78 | 2019 | |
| Boston Scientific Corporation | $13.46 | 2020 | |
| Novartis Pharmaceuticals Corporation | $12.94 | 2021 | |
| Medicomp INC | $11.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nasir Rahmatullah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.